BDF
ABMD

Balasa Dinverno & Foltz’s Abiomed Inc ABMD Stock Holding History

Balasa Dinverno & Foltz’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,133
Closed -$295K – 272
2019
Q2 		$295K Sell
1,133
-769
-40% -$204K 0.03% 188
2019
Q1 		$543K Sell
1,902
-338
-15% -$112K 0.07% 123
2018
Q4 		$728K Sell
2,240
-371
-14% -$129K 0.09% 95
2018
Q3 		$1.17M Sell
2,611
-36
-1% -$14.2K 0.13% 63
2018
Q2 		$1.08M Buy
2,647
+235
+10% +$85.1K 0.16% 63
2018
Q1 		$702K Buy
2,412
+180
+8% +$45.6K 0.11% 85
2017
Q4 		$418K Sell
2,232
-134
-6% -$25K 0.06% 133
2017
Q3 		$399K Sell
2,366
-245
-9% -$37K 0.06% 140
2017
Q2 		$374K Sell
2,611
-235
-8% -$31.6K 0.06% 143
2017
Q1 		$356K Sell
2,846
-174
-6% -$20.2K 0.06% 137
2016
Q4 		$340K Sell
3,020
-928
-24% -$108K 0.06% 132
2016
Q3 		$508K Buy
3,948
+34
+0.9% +$4.07K 0.09% 93
2016
Q2 		$428K Buy
+3,914
New +$389K 0.08% 106

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Balasa Dinverno & Foltz's ABMD Position: Q3 2019 in Review

Balasa Dinverno & Foltz sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,133 shares — an estimated $295K sold.

Balasa Dinverno & Foltz first reported a position in ABMD in Q2 2016 and held it in 13 quarters. The position peaked at $1.17M in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Balasa Dinverno & Foltz reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Balasa Dinverno & Foltz sold 1,133 Abiomed Inc shares in Q3 2019, an estimated $295K.
  • Balasa Dinverno & Foltz first reported a position in Abiomed Inc in Q2 2016 and held it in 13 quarters.
  • Balasa Dinverno & Foltz's Abiomed Inc position peaked at $1.17M in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2019, filed 6 Nov 2019.